Vanberra Signal
Free trial

BotImage

Curated by Signal

Provider of AI-based image interpretation for MRI for prostrate cancer detection

Life Sciences Technologybotimageai.com

Overview

Provider of AI-based image interpretation for MRI for prostate cancer detection. It offers Prostate ID software for the early diagnosis of cancer and COPD. It also offers radiologist interpretations, segmented prostate gland image sets, pathology laboratory results, correlation data, and others.

Key facts

Founded
2018
Headquarters
Omaha, United States
Stage
Sign up to view
Industry
Life Sciences Technology

Business model

2 products and services
Sign up to view
Commercial model
Sign up to view

Contact

Primary office
Sign up to view
Email
Sign up to view
Phone
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • FOXO Technologies

    Provider of epigenetic biomarkers discovery and development platform

    Life Sciences TechnologyMinneapolis, United States

  • FORE-SIGHT

    Cerebral oximetry device

    Life Sciences TechnologyBranford, United States

About BotImage

What does BotImage do?

Provider of AI-based image interpretation for MRI for prostate cancer detection.

Where is BotImage headquartered?

BotImage is headquartered in Omaha, United States.

When was BotImage founded?

BotImage was founded in 2018.

Which sector is BotImage in?

BotImage operates in Life Sciences Technology.

Who are BotImage's competitors?

Companies similar to BotImage include FOXO Technologies, Flexible Medical Systems, and FORE-SIGHT.